Wuhan General (PK) Stock Price

0.1146 (16.37%)


52 Week Range


Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Wuhan General Group Inc (PK) WUHN OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.1146 16.37% 0.8146 12:39:09
Open Price Low Price High Price Close Price Prev Close
0.71 0.7099 0.8146 0.70
Bid Price Ask Price Spread News
0.73 0.8098 0.0798 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10 13,900 $ 0.726373 $ 10,097 - 0.01705 - 1.09
Last Trade Time Type Quantity Stock Price Currency
11:50:42 201 $ 0.8146 USD

Wuhan General (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 44.43M 54.54M - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
33.99k $ - 0.00% - -

more financials information »

Wuhan General (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical WUHN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.6990.83480.670.724285223,0290.115616.54%
1 Month0.850.980.500.810554146,004-0.0354-4.16%
3 Months0.341151.090.341150.745811199,6470.47345138.78%
6 Months0.32491.090.210.494039140,4530.4897150.72%
1 Year0.031.090.017050.3646285163,4350.78462,615.33%
3 Years0.45021.090.017050.316022682,6280.364480.94%
5 Years0.0251.090.010.309058475,1310.78963,158.4%

Wuhan General (PK) Description

Wuhan General Group, Inc. (DBA M2bio Sciences) , is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms based products under Dr. AnnaRx, Medspresso and Handcrafted Delights brands. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research and emerging technologies.

Your Recent History
Wuhan Gene..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.